Negative regulation of Hif1a expression and TH 17 differentiation by the hypoxia-regulated microRNA miR-210

Nature Immunology

Volumn 15, Issue 4, 2014, Pages 393-401

  Wang, Haopeng ^a   Flach, Henrik ^a   Onizawa, Michio ^a   Wei, Lai ^b   Mcmanus, Michael T ^c   Weiss, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; MICRORNA 210; OXYGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HIF 1A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL COLITIS; GENE DELETION; HYPOXIA; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; ANTIGENS, CD4; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; COLITIS, ULCERATIVE; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; RNA INTERFERENCE; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84897051446     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2846     Document Type: Article

References (56)

1. Caldwell, C.C. et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167, 6140-6149 (2001.
2. McNamee, E.N., Korns Johnson, D., Homann, D. & Clambey, E.T. Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol. Res. 55, 58-70 (2013.
3. Ye, J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. 33, 54-66 (2009.
4. Bedogni, B. et al. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8, 443-454 (2005.
5. Taylor, C.T. & Colgan, S.P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295-1300 (2007.
6. Semenza, G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8 (2007.
7. Wang, G.L., Jiang, B.H., Rue, E.A. & Semenza, G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510-5514 (1995.
8. Maxwell, P.H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275 (1999.
9. Jaakkola, P. et al. Targeting of HIF-a to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472 (2001.
10. Bruning, U. et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1a activity during prolonged hypoxia. Mol. Cell. Biol. 31, 4087-4096 (2011.
11. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009.
12. Weaver, C.T., Hatton, R.D., Mangan, P.R. & Harrington, L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007.
13. Fife, B.T. et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 10, 1185-1192 (2009.
14. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 (2009.
15. Dang, E.V. et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 146, 772-784 (2011.
16. Shi, L.Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376 (2011.
17. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009.
18. Leung, A.K. & Sharp, P.A. MicroRNA functions in stress responses. Mol. Cell 40, 205-215 (2010.
19. Chan, Y.C., Banerjee, J., Choi, S.Y. & Sen, C.K. miR-210: The master hypoxamir. Microcirculation 19, 215-223 (2012.
20. Camps, C. et al. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348 (2008.
21. Giannakakis, A. et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7, 255-264 (2008.
22. Kulshreshtha, R. et al. A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867 (2007.
23. Mok, Y. et al. MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J. Immunol. 191, 3037-3048 (2013.
24. O'Connell, R.M., Rao, D.S., Chaudhuri, A.A. & Baltimore, D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122 (2010.
25. Baumjohann, D. & Ansel, K.M. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat. Rev. Immunol. 13, 666-678 (2013.
26. Kuchen, S. et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32, 828-839 (2010.
27. Chong, M.M. et al. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev. 24, 1951-1960 (2010.
28. Thai, T.H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604-608 (2007.
29. Fraser, J.D., Irving, B.A., Crabtree, G.R. & Weiss, A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316 (1991.
30. Stittrich, A.B. et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11, 1057-1062 (2010.
31. Kane, L.P., Andres, P.G., Howland, K.C., Abbas, A.K. & Weiss, A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines. Nat. Immunol. 2, 37-44 (2001.
32. Huang, X. et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35, 856-867 (2009.
33. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012.
34. Park, C.Y. et al. A resource for the conditional ablation of microRNAs in the mouse. Cell Rep 1, 385-391 (2012.
35. Wang, X. & El Naqa, I.M. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332 (2008.
36. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005.
37. John, B. et al. Human microRNA targets. PLoS Biol. 2, e363 (2004.
38. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. & Burge, C.B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003.
39. Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010.
40. Huang, X. & Zuo, J. Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response. Acta Biochim. Biophys. Sin. doi:10.1093/abbs/ gmt141 (6 January 2014.
41. Tsuchiya, S. et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 286, 420-428 (2011.
42. Favaro, E. et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5, e10345 (2010.
43. Chi, S.W., Zang, J.B., Mele, A. & Darnell, R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486 (2009.
44. Loeb, G.B. et al. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 48, 760-770 (2012.
45. Ikejiri, A. et al. Dynamic regulation of Th17 differentiation by oxygen concentrations. Int. Immunol. 24, 137-146 (2012.
46. Westermann, J. & Bode, U. Distribution of activated T cells migrating through the body: A matter of life and death. Immunol. Today 20, 302-306 (1999.
47. Vaupel, P., Thews, O., Kelleher, D.K. & Hoeckel, M. Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454, 591-602 (1998.
48. Henze, A.T. et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 70, 357-366 (2010.
49. Minamishima, Y.A. et al. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol. Cell. Biol. 29, 5729-5741 (2009.
50. Stiehl, D.P. et al. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491 (2006.
51. Park, C.Y., Choi, Y.S. & McManus, M.T. Analysis of microRNA knockouts in mice. Hum. Mol. Genet. 19, R169-R175 (2010.
52. Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 (2011.
53. Hoyer, K.K., Kuswanto, W.F., Gallo, E. & Abbas, A.K. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood 113, 389-395 (2009.
54. Steiner, D.F. et al. MicroRNA-29 regulates T-box transcription factors and interferon-gamma production in helper T cells. Immunity 35, 169-181 (2011.
55. Wang, H. et al. Tonic ubiquitylation controls T-cell receptor: CD3 complex expression during T-cell development. EMBO J. 29, 1285-1298 (2010.
56. Yamaji, O. et al. The development of colitogenic CD4+ T cells is regulated by IL-7 in collaboration with NK cell function in a murine model of colitis. J. Immunol. 188, 2524-2536 (2012.